Activity 3. Multiple Myeloma (MM)
- Standardization of the clinical data and biobanking
- outcome of populations of special interest
- Evaluation of Minimal Residual Disease (MRD)
- Analysis of DNA damage response and repair
- MM induced epigenetic changes
Coordinators
Professor Dr. H. Goldschmidt, Professor Dr. A. Dimitrakopoulou-Strauss (DKFZ) / Professor M.A. Dimopoulos, Ass. Prof. E. Terpos, Ass. Prof. E. Kastritis ( Univ. Athens), Dr. V. Souliotis (NHRF)
Key researchers-clinicians: Coordinators, Dr. C. Sachpekidis (DKFZ)
Other collaborative grants
- ELMUMY (Elucidation of risk factors and health determinants associated with progression of Monoclonal Gammopathies to Multiple Myeloma), submitted under the Horizon Europe HORIZON-MISS-2021-CANCER-02 call, has been selected for funding by the European Commission, having achieved the highest score of all proposals that were submitted (14.5/15). [Read more]
